Both in Biotechnology
Scribe Therapeutics vs SAB Biotherapeutics
Over the past year SCTX returned −48.2% and SABS returned −1.8%; their daily moves had a correlation of 0.22.
SCTX −48.2% SABS −1.8%Growth of $1, one year, split-adjusted
| Metric | SCTX | SABS |
|---|---|---|
| Price | $15.42 | $3.35 |
| Market cap | $291.9M | $304.8M |
| Today | −11.58% | +3.72% |
| 1 month | −10.2% | +9.5% |
| 6 months | — | −3.5% |
| Year to date | — | −10.4% |
| 1 year | — | +10.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $99.4M |
| Dividend yield | — | — |
| Volatility (60d) | — | 55.7% |
| Short % of float | 14.6% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).